SIGA Technologies Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SIGA Technologies, Inc. on November 5, 2008, covering events that occurred on October 30, 2008. The filing addresses corporate governance changes, specifically the expansion of the Board of Directors and the appointment of new members.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and does not contain financial performance data.
Material Changes
- Board Expansion: The Board of Directors increased the maximum size of the Board from ten to twelve members.
- New Appointments: Bruce Slovin (71) and Michael J. Bayer (60) were appointed to fill the new vacancies, effective immediately. Their terms extend through the next annual meeting of stockholders.
- Committee Assignment: Mr. Slovin was appointed to the Compensation Committee.
- Bylaw Amendment: Section 3.1 of the Company's Bylaws was amended to reflect the increase in the maximum Board size.
Compensation and Equity Grants
Upon appointment, Mr. Slovin and Mr. Bayer received compensation consistent with other Board members. Each was granted fully vested stock options to purchase 25,000 shares of SIGA's common stock. The exercise price was set at $3.14 per share, representing the closing market price on October 30, 2008.
Outlook, Risks, and Contingencies
The filing text does not provide a clear value for guidance, outlook, management commentary on future operations, risks, or contingencies.
Key Facts for Investor Verification
- Verify the total number of outstanding shares and the dilution impact of the 50,000 new stock options granted.
- Confirm the professional backgrounds of Bruce Slovin and Michael J. Bayer to assess their fit for the Board and Compensation Committee.
- Review the full text of the Bylaw Amendment (Exhibit 3.1) for any additional governance changes not summarized in the main text.
- Check the closing stock price of $3.14 on October 30, 2008, to validate the exercise price of the granted options.